First report of tirofiban-induced anemia (found in combination with severe thrombocytopenia).
暂无分享,去创建一个
[1] M. J. Tafreshi,et al. Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists. , 2006, The American journal of cardiology.
[2] E. Topol,et al. Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary Stenting , 2004, Circulation.
[3] D. Cines,et al. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. , 2004, Current hematology reports.
[4] R. Aster,et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. , 2002, Blood.
[5] F. Menapace,et al. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. , 2000, American heart journal.
[6] J. Tcheng. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment. , 2000, American heart journal.
[7] M. Madan,et al. Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors. , 1999, American heart journal.
[8] J. Ioannidis,et al. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. , 2003, Journal of the American College of Cardiology.
[9] R. Aster. Drug-induced immune thrombocytopenia: an overview of pathogenesis. , 1999, Seminars in hematology.